Justine V. Cohen

11.9k citations

96 papers · 3.4k indexed · 2 hit papers · h-index 22

Oncology top 1%
- Cancer Immunotherapy and Biomarkers 48
- CAR-T cell therapy research 15
- Cutaneous Melanoma Detection and Management 12
- Colorectal Cancer Treatments and Studies 12
Genetics top 2%
- Glioma Diagnosis and Treatment 9
Immunology top 5%
- Immunotherapy and Immune Responses 13
Pulmonary and Respiratory Medicine top 5%
- Brain Metastases and Treatment 18
Cardiology and Cardiovascular Medicine top 5%
Molecular Biology
- Melanoma and MAPK Pathways 18

Co-authors: Ryan J. Sullivan Donald P. Lawrence Kerry L. Reynolds Harriet M. Kluger Alexander T. Faje Tomas G. Neilan Lucie Heinzerling Paaladinesh Thavendiranathan
Cited by: Oncology Genetics Immunology
Journals: New England Journal of Medicine (1 paper)Journal of Clinical Oncology (30 papers)SHILAP Revista de lepidopterología (1 paper)
Partner nations: United States Canada France

In The Last Decade

Justine V. Cohen

86 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Justine V. Cohen

Since Specialization

Citations

This map shows the geographic impact of Justine V. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justine V. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justine V. Cohen more than expected).

Fields of papers citing papers by Justine V. Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justine V. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justine V. Cohen. The network helps show where Justine V. Cohen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Justine V. Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Justine V. Cohen Line = papers co-authored together Justine V. Cohen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma Cancer Research Communications ·Elizabeth I. Buchbinder,Justine V. Cohen,Giuseppe Tarantino,Christine G. Lian,David Liu,Rizwan Haq,F. Stephen Hodi,Donald P. Lawrence,Anita Giobbie‐Hurder,Deborah Knoerzer,Ryan J. Sullivan	2024	7
2	Safety and efficacy of first-in-class CXCR1/2 inhibitor SX-682 in combination with pembrolizumab (pem) in patients (pts) with metastatic melanoma (mMEL) with disease progression on anti–PD-1 therapy. Journal of Clinical Oncology ·Sapna P. Patel,Anastasios Dimou,Adrienne I. Victor,Meghan J. Mooradian,Elizabeth I. Buchbinder,Leonel F. Hernandez‐Aya,Peter A. Prieto,Justine V. Cohen,Keith T. Flaherty,Stuart J. Kahn,Aaron D. Schuler,Dean Y. Maeda,John A. Zebala	2024	10
3	Inherited Basaloid Neoplasms Associated With SUFU Pathogenic Variants JAMA Dermatology ·James Abbott,Angela J. Jiang,Rama Godse,Sarah Ahmed,Stephen C. Senft,Melissa Wilson,Justine V. Cohen,Tara C. Mitchell,Temitayo Ogunleye,H. William Higgins,Thuzar M. Shin,Christopher J. Miller,Jacquelyn J. Roth,Salvatore F. Priore,Leslie Castelo‐Soccio,Rosalie Elenitsas,John T. Seykora,Katherine L. Nathanson,Emily Y. Chu	2024	0
4	1137P Efficacy of LNS8801 in melanoma patients with prior immune-related adverse events from immune-checkpoint inhibitors Annals of Oncology ·Justine V. Cohen,T.K. Garyantes,Carolyn Y. Muller,Christopher A. Natale,M. Orloff,Snehal G. Patel,Jordi Rodon,A.N. Shoushtari	2024	1
5	627 The effect of LNS8801 in combination with pembrolizumab in patients with treatment-refractory cutaneous melanoma SHILAP Revista de lepidopterología ·Jordi Rodon,Marya Chaney,Justine V. Cohen,Tina Garyantes,(unknown),Jeffrey J. Ishizuka,Alain C. Mita,Monica Mita,Carolyn Y. Muller,Christopher A. Natale,Marlana Orloff,Kyriakos P. Papadopoulos,Sapna P. Patel,Alexander N. Shoushtari	2023	0
6	161TiP A phase I/II, open-label study of an anti-ILT2 (LILRB1) antibody, SAR444881, administered alone and in combination with pembrolizumab, with or without chemotherapy, or cetuximab in patients with advanced solid tumors Immuno-Oncology Technology ·Ruth Perets,Salomon M. Stemmer,Ravit Geva,Talia Golan,Marwan Fakih,Justine V. Cohen,Christopher H. Lieu,Zhaohui Jin,P. Lorusso,Natalia Ashtamker,I. Friedman,Motti Hakim,N. Crawford,Raymond P. Perez,Mansi Agarwal,Giovanni Abbadessa,Ming‐Shiang Wu,Yi-Chan Lin,Cecilia Deantonio,Mitesh J. Borad	2023	1
7	Dose‐escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF‐mutant solid tumors Cancer ·Meghan J. Mooradian,James M. Cleary,Anita Giobbie‐Hurder,Lancia Darville,Aparna R. Parikh,Elizabeth I. Buchbinder,Justine V. Cohen,Donald P. Lawrence,Geoffrey I. Shapiro,Harold Keer,Helen X Chen,Susan Percy Ivy,Keiran S.M. Smalley,John M. Koomen,Ryan J. Sullivan	2023	7
8	Neoadjuvant Nivo/Rela for Resectable Melanoma David M. Miller,Howard L. Kaufman,Kevin S. Emerick,(unknown),Justine V. Cohen,Emily Kim,Sophia Z. Shalhout	2022	2
9	Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy The Oncologist ·Emily J. Anstadt,Brian Chu,Nikhil Yegya‐Raman,Xiaoyan Han,Abigail Doucette,Kendra Poirier,Jahan J. Mohiuddin,Amit Maity,Andrea Facciabene,Ravi K. Amaravadi,Giorgos C. Karakousis,Justine V. Cohen,Tara C. Mitchell,Lynn M. Schuchter,John N. Lukens	2022	4
10	Neoadjuvant ICI for Resectable CSCC David M. Miller,Vishal Patel,Justine V. Cohen,Khalid Garmen,Sophia Z. Shalhout,(unknown)	2022	0
11	Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort Journal for ImmunoTherapy of Cancer ·Xue Bai,Michelle Kim,Gyulnara G. Kasumova,Lu Si,Bixia Tang,Chuanliang Cui,Xiaoling Yang,Xiaoting Wei,Justine V. Cohen,Donald P. Lawrence,Christine Freedman,Riley Fadden,Krista M. Rubin,Tatyana Sharova,Dennie T. Frederick,Keith T. Flaherty,Ryan J. Sullivan,Jun Guo,Genevieve M. Boland	2021	8
12	Rejection of benign melanocytic nevi by nevus-resident CD4 ⁺ T cells Science Advances ·Erik B. Schiferle,Scarlett Se Yun Cheon,Seokjin Ham,Heehwa G. Son,Jonathan L. Messerschmidt,Donald P. Lawrence,Justine V. Cohen,Keith T. Flaherty,James J. Moon,Christine G. Lian,Ryan J. Sullivan,Shadmehr Demehri	2021	9
13	Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma Kidney Medicine ·Harish Seethapathy,Halla Bates,Donald F. Chute,Ian A. Strohbehn,Samuel Strohbehn,Riley Fadden,Kerry L. Reynolds,Justine V. Cohen,Ryan J. Sullivan,Meghan E. Sise	2020	7
14	Anti–PD-1–Induced Pneumonitis Is Associated with Persistent Imaging Abnormalities in Melanoma Patients Cancer Immunology Research ·Douglas B. Johnson,Kevin B. Taylor,Justine V. Cohen,Noura Ayoubi,Alexandra M. Haugh,Daniel Wang,Brian D. Schlick,Amber L. Voorhees,Kenneth L. Gage,Florian J. Fintelmann,Ryan J. Sullivan,Zeynep Eroglu,Richard G. Abramson	2019	20
15	Immune checkpoint inhibitor related neurologic adverse events: clinical spectrum, management and outcomes (S21.003) Neurology ·Divyanshu Dubey,William David,Kerry L. Reynolds,Donald F. Chute,Nathan F. Clement,Justine V. Cohen,Donald P. Lawrence,Meghan J. Mooradian,Ryan J. Sullivan,Amanda C. Guidon	2019	2
16	Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events Journal for ImmunoTherapy of Cancer ·Yousef R. Badran,Justine V. Cohen,Priscilla K. Brastianos,Aparna R. Parikh,Theodore S. Hong,Michael Dougan	2019	107
17	Myocarditis in Patients Treated With Immune Checkpoint Inhibitorsbreakdown → Journal of the American College of Cardiology ·Syed Mahmood,Michael G. Fradley,Justine V. Cohen,Anju Nohria,Kerry L. Reynolds,Lucie Heinzerling,Ryan J. Sullivan,Rongras Damrongwatanasuk,Carol L. Chen,Dipti Gupta,Michael Constantin Kirchberger,Magid Awadalla,Malek Hassan,Javid J. Moslehi,Sachin Shah,Sarju Ganatra,Paaladinesh Thavendiranathan,Donald P. Lawrence,John D. Groarke,Tomas G. Neilan	2018	1050
18	PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors Clinical Cancer Research ·Harriet M. Kluger,Christopher R. Zito,Gabriela Turcu,Marina K. Baine,Hongyi Zhang,Adebowale Adeniran,Mario Sznol,David L. Rimm,Yuval Kluger,Lieping Chen,Justine V. Cohen,Lucia B. Jilaveanu	2017	111
19	Systemic Immunotherapy for the Treatment of Brain Metastases Frontiers in Oncology ·Justine V. Cohen,Harriet M. Kluger	2016	60
20	Case reports: minocycline-induced hyperpigmentation resolves during oral isotretinoin therapy. PubMed ·Jennifer Soung,Justine V. Cohen,Robert Phelps,Steven R. Cohen	2007	10

About Justine V. Cohen

Justine V. Cohen is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 96 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (48 papers), Brain Metastases and Treatment (18 papers), Melanoma and MAPK Pathways (18 papers), CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (13 papers), Cutaneous Melanoma Detection and Management (12 papers), Colorectal Cancer Treatments and Studies (12 papers) and Glioma Diagnosis and Treatment (9 papers). The work is most often cited by research in Oncology (2.4k citations), Genetics (369 citations) and Immunology (583 citations). Justine V. Cohen has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Ryan J. Sullivan, Donald P. Lawrence, Kerry L. Reynolds, Harriet M. Kluger, Alexander T. Faje, Tomas G. Neilan, Lucie Heinzerling, Paaladinesh Thavendiranathan, Syed Mahmood and Sarju Ganatra. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact